Du, Zhenfang
Lovly, Christine M.
Funding for this research was provided by:
National Institutes of Health (R01CA121210, P01CA129243, U10CA180864, P30CA068485-13S5)
Article History
Received: 4 January 2018
Accepted: 1 February 2018
First Online: 19 February 2018
Ethics approval and consent to participate
: Not applicable
: Not applicable
: ZD reports no potential conflicts of interest. CML has served as a consultant for Pfizer, Novartis, Astra Zeneca, Genoptix, Sequenom, ARIAD, Takeda, and Foundation Medicine and has been an invited speaker for Abbott and Qiagen.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.